Transitioning from Private to Public: Life Sciences IPO Exit Strategies – Hosted by Deloitte
A virtual discussion presented by Deloitte’s Capital Markets Transactions practice. Please join Deloitte Life Sciences IPO leaders Tasia Blazevich and B.J. Spence as they lead...